ADAM C KAPLAN

Allopathic & Osteopathic Physicians|Internal Medicine NEPTUNE, NJ NPI 1013330018

General Payments — all program years on this page

$1,137.63

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 55
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $427.08 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $427.0817

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $128.607
Lilly USA, LLC $125.001
Abbott Laboratories $63.973
Novo Nordisk AS $41.152
PFIZER INC. $33.852
AIMMUNE THERAPEUTICS, INC. $19.431
Acerta Pharma LLC $15.081

By program year

Program yearAmountRecords
2018 $182.3213
2019 $250.7310
2020 $49.653
2022 $86.435
2023 $141.427
2024 $427.0817

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096901455 Novo Nordisk Inc $25.00 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096929126 Novo Nordisk Inc $16.15 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104029913 ABBVIE INC. $17.67 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104029915 ABBVIE INC. $17.41 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104029917 ABBVIE INC. $18.05 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104029919 ABBVIE INC. $18.64 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104029921 ABBVIE INC. $18.56 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104029923 ABBVIE INC. $20.43 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104029925 ABBVIE INC. $17.84 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105405691 AstraZeneca Pharmaceuticals LP $15.08 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124795279 Abbott Laboratories $22.43 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124795284 Abbott Laboratories $22.31 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124795287 Abbott Laboratories $19.23 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131838096 PFIZER INC. $16.97 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132093842 PFIZER INC. $16.88 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136007609 Lilly USA, LLC $125.00 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146996214 AIMMUNE THERAPEUTICS, INC. $19.43 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.